SYLOID® 244 FP meets the requirements of the monograph for silicon dioxide as stated in the latest USP/NF and Japanese Pharmaceutical Excipients(JPE) editions. The use of fumed silica as an excipient ingredient for pharmaceutical formulations, particularly in tablets and as a carrier for liquids is well known. However, compared with fumed silica, SYLOID® 244 FP silica is larger in particle size and has a higher density. This translates into a product that is much less dusty than fumed and is easier to handle and to incorporate into your formulation.

SYLOID® XDP 3050 is a highly effective excipient for pharmaceutical applications that delivers superior performance and versatility. This engineered, highly porous silica excipient is designed to deliver superior flowability, compressibility, and adsorption properties to a variety of pharmaceutical formulations. SYLOID® XDP 3050 is an excellent choice for drug formulations that require consistent flow properties, improved compressibility, and higher active pharmaceutical ingredient (API) loading. Its unique morphology and high surface area provide excellent binding and adsorption properties, making it ideal for use in solid oral dosage forms, such as tablets and capsules. In addition to its exceptional performance, SYLOID® XDP 3050 is also highly compatible with a wide range of pharmaceutical ingredients and manufacturing processes. Its ability to improve the quality and consistency of pharmaceutical formulations while reducing production costs makes it a highly valuable and versatile excipient for the pharmaceutical industry.